KNB Stock Overview
Engages in the development and distribution of cannabis-derived solutions for medical and wellness products.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Kanabo Group Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.016 |
52 Week High | UK£0.032 |
52 Week Low | UK£0.011 |
Beta | 3.15 |
1 Month Change | -8.57% |
3 Month Change | -11.11% |
1 Year Change | -43.86% |
3 Year Change | -91.79% |
5 Year Change | n/a |
Change since IPO | -96.08% |
Recent News & Updates
Recent updates
Shareholder Returns
KNB | GB Pharmaceuticals | GB Market | |
---|---|---|---|
7D | -8.6% | -0.9% | 1.0% |
1Y | -43.9% | 7.4% | 6.7% |
Return vs Industry: KNB underperformed the UK Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: KNB underperformed the UK Market which returned 6.8% over the past year.
Price Volatility
KNB volatility | |
---|---|
KNB Average Weekly Movement | 10.8% |
Pharmaceuticals Industry Average Movement | 7.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: KNB has not had significant price volatility in the past 3 months.
Volatility Over Time: KNB's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 17 | Avihu Tamir | www.kanabogroup.com |
Kanabo Group Plc engages in the development and distribution of cannabis-derived solutions for medical and wellness products. It operates through Primary Care and Secondary Care segments. The company offers non- tetrahydrocannabinol products for cannabidiol consumers.
Kanabo Group Plc Fundamentals Summary
KNB fundamental statistics | |
---|---|
Market cap | UK£10.12m |
Earnings (TTM) | -UK£7.99m |
Revenue (TTM) | UK£895.00k |
11.3x
P/S Ratio-1.3x
P/E RatioIs KNB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KNB income statement (TTM) | |
---|---|
Revenue | UK£895.00k |
Cost of Revenue | UK£761.00k |
Gross Profit | UK£134.00k |
Other Expenses | UK£8.12m |
Earnings | -UK£7.99m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.013 |
Gross Margin | 14.97% |
Net Profit Margin | -892.40% |
Debt/Equity Ratio | 3.6% |
How did KNB perform over the long term?
See historical performance and comparison